Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.50%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
30.14 0.48(1.57%) Jul 25, 4:00PM EDT
Prev Close:30.62
Open:30.19
Bid:29.47 x 100
Ask:33.63 x 100
1y Target Est:43.56
Beta:1.63
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:29.62 - 30.37
52wk Range:22.25 - 62.66
Volume:916,844
Avg Vol (3m):2,818,140
Market Cap:3.54B
P/E (ttm):N/A
EPS (ttm):-0.79
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ISISDown 1.57%3.54B
ENZ219.57M
GILD137.10B
SRPT837.15M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):27.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.71
Quarterly EPS Est (Jun-14) :-0.12
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-1.87

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients w... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback